Institutional Fund
Gsk PLC
London, United KingdomCIK 11313992 filings on record
Portfolio Value
$599.15M
Q1 2026
Holdings
13
Reported positions
New Buys
0
Opened this quarter
QoQ Change
-25.0%
from $799.02M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Crispr Therapeutics AG25.6%
- Wave Life Sciences Ltd22.1%
- Biontech Se13.2%
- Vir Biotechnology Inc12.8%
- Ideaya Biosciences Inc7.4%
- Lyell Immunopharma Inc5.1%
- Other13.9%
Portfolio Holdings
13 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Crispr Therapeutics AG | 3.22M | $153.21M | 25.6% | 0 | Held |
| 2 | Wave Life Sciences Ltd | 18.25M | $132.28M | 22.1% | 0 | Held |
| 3 | Biontech Se | 889.8K | $79.09M | 13.2% | 0 | Held |
| 4 | Vir Biotechnology Inc | 8.55M | $76.62M | 12.8% | 0 | Held |
| 5 | Ideaya Biosciences Inc | 1.33M | $44.43M | 7.4% | 0 | Held |
| 6 | Lyell Immunopharma Inc | 1.51M | $30.34M | 5.1% | 0 | Held |
| 7 | Cytokinetics Inc | 340.4K | $22.44M | 3.7% | 0 | Held |
| 8 | Spero Therapeutics Inc | 9.19M | $21.51M | 3.6% | 0 | Held |
| 9 | Fulcrum Therapeutics Inc | 1.79M | $13.70M | 2.3% | 0 | Held |
| 10 | Cvrx Inc | 1.01M | $9.53M | 1.6% | 0 | Held |
3 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio